FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904231350> ?p ?o ?g. }

• W2904231350 endingPage "106" @default.
• W2904231350 startingPage "98" @default.
• W2904231350 abstract "Cesarean delivery occurs in roughly one third of pregnancies. Effective postoperative pain control is a goal for patients and physicians. Limiting opioid use in this period is important as some percentage of opioid naïve individuals will develop persistent use. Gabapentin is a non-opioid medication that has been used perioperatively to improve postoperative pain and limit opioid requirements. The goal of this study is to determine the efficacy of perioperative gabapentin in improving post cesarean delivery pain control. The following data sources were searched from their inception through October 2018: MEDLINE, Ovid, ClinicalTrials.gov, Sciencedirect, and the Cochrane Library at the CENTRAL Register of Controlled Trials. A systematic review of the literature was performed to include all randomized trials examining the effect of perioperative gabapentin on post cesarean delivery pain control and other postoperative outcomes. The primary outcome was the analgesic effect of gabapentin on post cesarean delivery pain, measured by visual analog scale (VAS; 0–100) or Numerical Rating Scale (NRS; 0–10) on movement 24 hours (h) postoperative. These scores were directly compared by multiplying all NRS scores by a factor of 10. Meta-analysis was performed using the random effects model of DerSimonian and Laird, to produce summary treatment effects in terms of mean difference (MD) with 95% confidence interval (CI). Six placebo controlled trials (n = 645) were identified as relevant and included in the meta-analysis. All studies included only healthy pregnant women (American Society of Anesthesiologist (ASA) physical status I or II) undergoing spinal anesthesia for cesarean delivery at term. Participants were randomized to either 600 mg oral gabapentin or placebo preoperatively and in one study the medications were also continued postoperatively. Pooled data showed that women who received gabapentin prior to cesarean delivery had significantly lower VAS pain scores at 24 h on movement (MD -11.58, 95% CI -23.04 to -0.12). VAS pain scores at other time points at rest or on movement were not significantly different for those who received gabapentin and placebo although there was a general trend toward lower pain scores for women receiving gabapentin. There was no significant between-group difference in use of additional pain medications, supplemental opioids, and maternal or neonatal side effects. There was higher pain control satisfaction at 12 and 24 h in the gabapentin versus placebo groups." @default.
• W2904231350 created "2018-12-22" @default.
• W2904231350 creator A5010335808 @default.
• W2904231350 creator A5054869197 @default.
• W2904231350 creator A5065033288 @default.
• W2904231350 creator A5074270038 @default.
• W2904231350 creator A5077323700 @default.
• W2904231350 creator A5082931017 @default.
• W2904231350 creator A5086525984 @default.
• W2904231350 date "2019-02-01" @default.
• W2904231350 modified "2023-10-05" @default.
• W2904231350 title "Perioperative gabapentin and post cesarean pain control: A systematic review and meta-analysis of randomized controlled trials" @default.
• W2904231350 cites W1638158922 @default.
• W2904231350 cites W1825455551 @default.
• W2904231350 cites W1969578025 @default.
• W2904231350 cites W1974067738 @default.
• W2904231350 cites W1990251399 @default.
• W2904231350 cites W2007872832 @default.
• W2904231350 cites W2073797345 @default.
• W2904231350 cites W2082927421 @default.
• W2904231350 cites W2103312929 @default.
• W2904231350 cites W2136495957 @default.
• W2904231350 cites W2322401949 @default.
• W2904231350 cites W2343015609 @default.
• W2904231350 cites W2487384103 @default.
• W2904231350 cites W2565600523 @default.
• W2904231350 cites W2566155139 @default.
• W2904231350 cites W2602812109 @default.
• W2904231350 cites W2765679524 @default.
• W2904231350 cites W2793824942 @default.
• W2904231350 cites W2808040926 @default.
• W2904231350 cites W4231059629 @default.
• W2904231350 cites W4383480394 @default.
• W2904231350 doi "https://doi.org/10.1016/j.ejogrb.2018.11.026" @default.
• W2904231350 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30583095" @default.
• W2904231350 hasPublicationYear "2019" @default.
• W2904231350 type Work @default.
• W2904231350 sameAs 2904231350 @default.
• W2904231350 citedByCount "19" @default.
• W2904231350 countsByYear W29042313502019 @default.
• W2904231350 countsByYear W29042313502020 @default.
• W2904231350 countsByYear W29042313502021 @default.
• W2904231350 countsByYear W29042313502022 @default.
• W2904231350 countsByYear W29042313502023 @default.
• W2904231350 crossrefType "journal-article" @default.
• W2904231350 hasAuthorship W2904231350A5010335808 @default.
• W2904231350 hasAuthorship W2904231350A5054869197 @default.
• W2904231350 hasAuthorship W2904231350A5065033288 @default.
• W2904231350 hasAuthorship W2904231350A5074270038 @default.
• W2904231350 hasAuthorship W2904231350A5077323700 @default.
• W2904231350 hasAuthorship W2904231350A5082931017 @default.
• W2904231350 hasAuthorship W2904231350A5086525984 @default.
• W2904231350 hasConcept C126322002 @default.
• W2904231350 hasConcept C141071460 @default.
• W2904231350 hasConcept C14184104 @default.
• W2904231350 hasConcept C142724271 @default.
• W2904231350 hasConcept C168563851 @default.
• W2904231350 hasConcept C170493617 @default.
• W2904231350 hasConcept C204787440 @default.
• W2904231350 hasConcept C27081682 @default.
• W2904231350 hasConcept C2776478404 @default.
• W2904231350 hasConcept C2776608144 @default.
• W2904231350 hasConcept C2780820201 @default.
• W2904231350 hasConcept C2781063702 @default.
• W2904231350 hasConcept C31174226 @default.
• W2904231350 hasConcept C42219234 @default.
• W2904231350 hasConcept C44249647 @default.
• W2904231350 hasConcept C71924100 @default.
• W2904231350 hasConcept C95190672 @default.
• W2904231350 hasConceptScore W2904231350C126322002 @default.
• W2904231350 hasConceptScore W2904231350C141071460 @default.
• W2904231350 hasConceptScore W2904231350C14184104 @default.
• W2904231350 hasConceptScore W2904231350C142724271 @default.
• W2904231350 hasConceptScore W2904231350C168563851 @default.
• W2904231350 hasConceptScore W2904231350C170493617 @default.
• W2904231350 hasConceptScore W2904231350C204787440 @default.
• W2904231350 hasConceptScore W2904231350C27081682 @default.
• W2904231350 hasConceptScore W2904231350C2776478404 @default.
• W2904231350 hasConceptScore W2904231350C2776608144 @default.
• W2904231350 hasConceptScore W2904231350C2780820201 @default.
• W2904231350 hasConceptScore W2904231350C2781063702 @default.
• W2904231350 hasConceptScore W2904231350C31174226 @default.
• W2904231350 hasConceptScore W2904231350C42219234 @default.
• W2904231350 hasConceptScore W2904231350C44249647 @default.
• W2904231350 hasConceptScore W2904231350C71924100 @default.
• W2904231350 hasConceptScore W2904231350C95190672 @default.
• W2904231350 hasLocation W29042313501 @default.
• W2904231350 hasLocation W29042313502 @default.
• W2904231350 hasOpenAccess W2904231350 @default.
• W2904231350 hasPrimaryLocation W29042313501 @default.
• W2904231350 hasRelatedWork W1985502152 @default.
• W2904231350 hasRelatedWork W2038029390 @default.
• W2904231350 hasRelatedWork W2055432693 @default.
• W2904231350 hasRelatedWork W2097084134 @default.
• W2904231350 hasRelatedWork W2125815930 @default.
• W2904231350 hasRelatedWork W2381982637 @default.
• W2904231350 hasRelatedWork W2531052508 @default.
• W2904231350 hasRelatedWork W3150365531 @default.

• next